Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
Seeking Alpha
Giancarlo Nicoli's
Instablog
Edit Picture
Giancarlo Nicoli
Giancarlo Nicoli
Stop Following
Giancarlo Nicoli
221
Followers
3
Following
Send Message
I work as a community pharmacist. I live in Northern Italy. My interests are not limited to: dividend and biotechnology investing.
My company:
QuestForYield
My blog:
QuestForYield.com
Profile
Articles (15)
Instablog (
5
)
Comments (130)
Posts on
Biotech
Posts by Giancarlo Nicoli
Dendreon: Management Signals Stock is Undervalued and a Potential Takeover Candidate
Thu, Jan 19, 2012
Posts by other instabloggers
AMRN: Vascepa Is Not Just Any Fish Oil
Fri, May 24
•
MSelv
Arrowhead Research: An Undervalued Biotech Company
Mon, May 20
•
exstrategist
Two Biotech Ideas You May Have Missed: William Gregozeski
Thu, May 16
•
Life Sciences Report
ISCO Has Promising Therapy For Parkinson's Disease
Sat, May 11
•
KarinCA
Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert
Fri, May 10
•
Life Sciences Report
All instablog posts on Biotech »
Share this content
Tweet
Search Seeking Alpha Articles for:
You can use: AND, NOT, OR, " " (exact phrase)
Search Transcripts for:
You can use: AND, NOT, OR, " " (exact phrase)
Posts by Themes
Biotech
,
Cancer
,
dividend-ideas
,
dont-tag-as-pro
,
income-investing-strategy
,
long-ideas
Instablogs
are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets.
Publish your own instablog
in minutes.
Posts on Biotech
Posts by Giancarlo Nicoli
Dendreon: Management Signals Stock is Undervalued and a Potential Takeover Candidate
Posts by other instabloggers
-
Fri, May 24
•
MSelv
-
Mon, May 20
•
exstrategist
-
Thu, May 16
•
Life Sciences Report
-
Sat, May 11
•
KarinCA
-
Fri, May 10
•
Life Sciences Report
All instablog posts on Biotech »AMRN: Vascepa Is Not Just Any Fish Oil
Arrowhead Research: An Undervalued Biotech Company
Two Biotech Ideas You May Have Missed: William Gregozeski
ISCO Has Promising Therapy For Parkinson's Disease
Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert